BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25897827)

  • 1. Development of Teratocarcinomas and Teratomas in Severely Immunodeficient NOD.Cg-Prkdc(scid) Il2rg(tm1Wjl)/Szj (NSG) Mice.
    Lim CY; Solter D; Knowles BB; Damjanov I
    Stem Cells Dev; 2015 Jul; 24(13):1515-20. PubMed ID: 25897827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A germline-competent embryonic stem cell line from NOD.Cg-Prkdc ( scid ) Il2rg ( tm1Wjl )/SzJ (NSG) mice.
    Landel CP; Dunlap J; Patton JB; Manser T
    Transgenic Res; 2013 Feb; 22(1):179-85. PubMed ID: 22767020
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    St Jean SC; Ricart Arbona RJ; Mishkin N; Monette S; Wipf JRK; Henderson KS; Cheleuitte-Nieves C; Lipman NS; Carrasco SE
    Vet Pathol; 2024 Jan; 61(1):145-156. PubMed ID: 37434451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outbreak of Opportunistic Ascending Pyelonephritis with Numerous Yeast after Experimental Humanization Surgery in NOD.Cg-
    Zadrozny LM; Brinster LR; Rosenzweig BA; Howard KE
    Comp Med; 2018 Oct; 68(5):353-359. PubMed ID: 30208988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degenerative Myelopathy and Neuropathy in NOD.
    Yang P; Freeman ZT; Dysko RC; Hoenerhoff MJ
    Toxicol Pathol; 2022 Apr; 50(3):390-396. PubMed ID: 35450478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Generation of a new strain of NOD/SCID/IL2Rγ
    Liu YC; Chen Q; Yang XL; Tang QS; Yao KT; Xu Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Jun; 38(6):639-646. PubMed ID: 29997084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reference Values for Hematology, Plasma Biochemistry, Bone Marrow Cytology and Bone Histology of NOD
    Layssol-Lamour CJ; Sarry JE; Braun JD; Trumel C; Bourgès-Abella NH
    J Am Assoc Lab Anim Sci; 2021 Jan; 60(1):4-17. PubMed ID: 33046180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative utility of NRG and NRGS mice for the study of normal hematopoiesis, leukemogenesis, and therapeutic response.
    Barve A; Casson L; Krem M; Wunderlich M; Mulloy JC; Beverly LJ
    Exp Hematol; 2018 Nov; 67():18-31. PubMed ID: 30125602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonirradiated NOD,B6.SCID Il2rγ-/- Kit(W41/W41) (NBSGW) mice support multilineage engraftment of human hematopoietic cells.
    McIntosh BE; Brown ME; Duffin BM; Maufort JP; Vereide DT; Slukvin II; Thomson JA
    Stem Cell Reports; 2015 Feb; 4(2):171-80. PubMed ID: 25601207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8-positive lymphocytes in graft-versus-host disease of humanized NOD.Cg-Prkdc(scid)Il2rg(tm1Wjl)/SzJ mice.
    Laing ST; Griffey SM; Moreno ME; Stoddart CA
    J Comp Pathol; 2015; 152(2-3):238-42. PubMed ID: 25670669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embryo-derived teratocarcinoma. III. Development of tumors from teratocarcinoma-permissive and non-permissive strain embryos transplanted to F1 hybrids.
    Solter D; Dominis M; Damjanov I
    Int J Cancer; 1981 Oct; 28(4):479-83. PubMed ID: 7309292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/scid-related strains.
    Agliano A; Martin-Padura I; Mancuso P; Marighetti P; Rabascio C; Pruneri G; Shultz LD; Bertolini F
    Int J Cancer; 2008 Nov; 123(9):2222-7. PubMed ID: 18688847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Embryo-derived teratocarcinoma: I. The role of strain and gender in the control of teratocarcinogenesis.
    Solter D; Dominis M; Damjanov I
    Int J Cancer; 1979 Dec; 24(6):770-2. PubMed ID: 544530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOD-scidIl2rg (tm1Wjl) and NOD-Rag1 (null) Il2rg (tm1Wjl) : a model for stromal cell-tumor cell interaction for human colon cancer.
    Maykel J; Liu JH; Li H; Shultz LD; Greiner DL; Houghton J
    Dig Dis Sci; 2014 Jun; 59(6):1169-79. PubMed ID: 24798995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental induction of embryo-derived teratomas and teratocarcinomas in mice.
    Bauer H; Kaltschmidt A; Müller M
    Arch Geschwulstforsch; 1989; 59(5):333-40. PubMed ID: 2589932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using CRISPR/Cas9 for Gene Knockout in Immunodeficient NSG Mice.
    Du Y; Xie W; Zhang F; Choi U; Liu C; Sweeney CL
    Methods Mol Biol; 2019; 1874():139-168. PubMed ID: 30353512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphologic and Immunohistochemical Characterization of Spontaneous Lymphoma/Leukemia in NSG Mice.
    Tillman H; Janke LJ; Funk A; Vogel P; Rehg JE
    Vet Pathol; 2020 Jan; 57(1):160-171. PubMed ID: 31736441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoencapsulated rituximab mediates superior cellular immunity against metastatic B-cell lymphoma in a complement competent humanized mouse model.
    Wen J; Wang L; Ren J; Kranz E; Chen S; Wu D; Kanazawa T; Chen I; Lu Y; Kamata M
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33593826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical variables affecting clinical-grade production of the self-inactivating gamma-retroviral vector for the treatment of X-linked severe combined immunodeficiency.
    van der Loo JC; Swaney WP; Grassman E; Terwilliger A; Higashimoto T; Schambach A; Hacein-Bey-Abina S; Nordling DL; Cavazzana-Calvo M; Thrasher AJ; Williams DA; Reeves L; Malik P
    Gene Ther; 2012 Aug; 19(8):872-6. PubMed ID: 22551777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo generation of transplantable human hematopoietic cells from induced pluripotent stem cells.
    Amabile G; Welner RS; Nombela-Arrieta C; D'Alise AM; Di Ruscio A; Ebralidze AK; Kraytsberg Y; Ye M; Kocher O; Neuberg DS; Khrapko K; Silberstein LE; Tenen DG
    Blood; 2013 Feb; 121(8):1255-64. PubMed ID: 23212524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.